Aurobindo Pharma Limited has submitted a regulatory disclosure to the Listing Department of the National Stock Exchange of India Limited and The Corporate Relations Department of BSE Limited regarding its participation in an investor meeting.
The company officials will participate in a group meeting organized by Goldman Sachs as part of their "CDMO Tour". The meeting is scheduled for June 12, 2026, from 3:30 PM to 5:00 PM IST. The meeting will take place in Hyderabad.
The disclosure specifically notes that the schedule is subject to change due to exigencies on the part of either the Investor or the Company. Most importantly, the company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
The letter was digitally signed by B. Adi Reddy, Company Secretary, on June 9, 2026, at 14:37:39 IST. The corporate office is located at Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
This filing serves as a routine regulatory compliance disclosure under exchange regulations for investor meeting participation.